X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (58) 58
humans (54) 54
infectious diseases (45) 45
immunology (38) 38
female (34) 34
hiv (34) 34
hiv infections - virology (34) 34
mutation (33) 33
drug resistance (30) 30
hiv infections - drug therapy (30) 30
male (29) 29
adult (28) 28
hiv-1 - genetics (28) 28
virology (27) 27
human immunodeficiency virus--hiv (23) 23
hiv-1 - drug effects (21) 21
aids/hiv (19) 19
antiretroviral therapy (19) 19
drug resistance, viral (19) 19
drug therapy (19) 19
middle aged (19) 19
research (19) 19
hiv infection (18) 18
antiretroviral drugs (17) 17
antiviral agents (17) 17
genotype (17) 17
microbiology (16) 16
viral load (15) 15
therapy (14) 14
treatment failure (14) 14
article (13) 13
drug-resistance (13) 13
mutations (13) 13
risk factors (13) 13
south africa (13) 13
virological failure (13) 13
drug resistance, viral - genetics (12) 12
hiv-1 - isolation & purification (12) 12
viruses (12) 12
acquired immune deficiency syndrome--aids (11) 11
anti-hiv agents - pharmacology (11) 11
anti-hiv agents - therapeutic use (11) 11
history (11) 11
hiv infections - epidemiology (11) 11
rna, viral - genetics (11) 11
anti-hiv agents - administration & dosage (10) 10
failure (10) 10
infection (10) 10
medicine (10) 10
south-africa (10) 10
sub-saharan africa (10) 10
virus diseases (10) 10
analysis (9) 9
dosage and administration (9) 9
immunodeficiency-virus type-1 (9) 9
resistance (9) 9
young adult (9) 9
aids (8) 8
genetic aspects (8) 8
highly active antiretroviral therapy (8) 8
hiv-1 (8) 8
prevalence (8) 8
prospective studies (8) 8
research article (8) 8
reverse transcriptase inhibitors - therapeutic use (8) 8
reverse-transcriptase (8) 8
sequence analysis, dna (8) 8
africa (7) 7
antiretroviral agents (7) 7
human immunodeficiency virus (7) 7
infectious disease (7) 7
laboratories (7) 7
multidisciplinary sciences (7) 7
prevention (7) 7
resource-limited settings (7) 7
rna, viral - blood (7) 7
united states (7) 7
abridged index medicus (6) 6
aged (6) 6
arts (6) 6
care and treatment (6) 6
cohort studies (6) 6
culture (6) 6
diagnosis (6) 6
health aspects (6) 6
hiv reverse transcriptase - genetics (6) 6
infected patients (6) 6
inhibitors (6) 6
molecular sequence data (6) 6
mutation, missense (6) 6
plasma (6) 6
reverse transcriptase inhibitors - administration & dosage (6) 6
ribonucleic acid--rna (6) 6
rna (6) 6
rna-directed dna polymerase (6) 6
sensitivity and specificity (6) 6
social conditions (6) 6
surveillance (6) 6
tenofovir (6) 6
usage (6) 6
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (13) 13
UofT at Mississauga - Stacks (2) 2
Architecture Landscape (Shore + Moffat) - Stacks (1) 1
Art - Library use only (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Stacks (1) 1
Knox College (Caven) - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Royal Ontario Museum - Far Eastern Egyptian (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Infectious Diseases, ISSN 0022-1899, 01/2019, Volume 219, Issue 4, pp. 673 - 674
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 01/2014, Volume 65, pp. S36 - S36
There are many challenges to performing clinical research in resource-limited settings. Here, we discuss several of the most common laboratory issues that must... 
Indexing in process
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 01/2014, Volume 65, p. S36
  There are many challenges to performing clinical research in resource-limited settings. Here, we discuss several of the most common laboratory issues that... 
Medical research | Laboratories | Resource management
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2011, Volume 11, Issue 10, pp. 750 - 759
Summary Background There are few data on the epidemiology of primary HIV-1 drug resistance after the roll-out of antiretroviral treatment (ART) in sub-Saharan... 
Infectious Disease | SURVEILLANCE | INFECTIOUS DISEASES | MUTATIONS | PREVALENCE | NEVIRAPINE | RECOMMENDATIONS | Anti-HIV Agents - pharmacology | Prevalence | Prospective Studies | Kenya - epidemiology | HIV Infections - epidemiology | Humans | Middle Aged | Uganda - epidemiology | Male | Anti-HIV Agents - administration & dosage | Adult | Female | HIV Infections - transmission | Zambia - epidemiology | Zimbabwe - epidemiology | Thymidine - genetics | Cross-Sectional Studies | HIV-1 - drug effects | HIV Infections - virology | South Africa - epidemiology | Genotype | Drug Resistance, Viral - genetics | Thymidine - analogs & derivatives | Analysis of Variance | Anti-Retroviral Agents - administration & dosage | Nigeria - epidemiology | Drug Resistance, Viral - drug effects | HIV Infections - drug therapy | Aged | Viral Load - drug effects | Africa South of the Sahara - epidemiology | Population Surveillance | Highly active antiretroviral therapy | Antiviral agents | HIV (Viruses) | Drug therapy | Drug resistance | HIV infection | Laboratories | Thymidine | Multivariate analysis | Epidemiology | Risk factors | Gene sequencing | Mathematical analysis | Antiretroviral agents | Human immunodeficiency virus--HIV | Pol gene | Pretreatment | Public health | Antiretroviral drugs | Calendars | Proteinase inhibitors | Risk analysis | Ribonucleic acid--RNA | Resistance factors | Antiretroviral therapy | CD4 antigen | Rolling resistance | Protease inhibitors | Adults | Mutation
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 04/2013, Volume 56, Issue 7, p. 1044
  Nevirapine (NVP) resistance emerges in up to 70% of women exposed to single-dose (sd) NVP for prevention of mother-to-child transmission of human... 
Disease prevention | Antiretroviral drugs | Disease transmission | Maternal & child health | Human immunodeficiency virus--HIV | Clinical trials | Drug resistance
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2012, Volume 12, Issue 4, pp. 307 - 317
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 05/2018, Volume 66, Issue 11, pp. 1689 - 1697
Limited data exist on initial human immunodeficiency virus type 1 (HIV-1) treatment with dolutegravir plus lamivudine. A5353 is a phase 2, single-arm, pilot... 
2-drug therapy | mutation | dolutegravir | naive | lamivudine | and Commentaries
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 06/2012, Volume 54, Issue 11, p. 1660
  Human immunodeficiency virus type 1 (HIV-1) drug resistance may limit the benefits of antiretroviral therapy (ART). This cohort study examined patterns of... 
Antiretroviral drugs | Inhibitor drugs | Human immunodeficiency virus--HIV | Mutation | Drug resistance | Drug therapy
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2012, Volume 54, Issue 11, pp. 1660 - 1669
Journal Article
Open Forum Infectious Diseases, ISSN 2328-8957, 2016, Volume 3, Issue 3, p. ofw154
The mechanism of virologic failure (VF) of lopinavir/ritonavir (LPV/r) monotherapy is not well understood. We assessed sequence changes in human... 
Drug resistance mutation | Phylogenetic | Hamming distance | LPV/r failures | HIV-1 sequence evolution
Journal Article
PLoS ONE, ISSN 1932-6203, 2015, Volume 10, Issue 12, p. e0145772
The increasing prevalence of acquired and transmitted HIV-1 drug resistance is an obstacle to successful antiretroviral therapy (ART) in the low- and... 
PROTEASE INHIBITOR | SOUTH-AFRICA | NAIVE INDIVIDUALS | RESOURCE-LIMITED SETTINGS | SUB-SAHARAN AFRICA | VIROLOGICAL FAILURE | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | TREATMENT PROGRAMS | HIV-1-INFECTED PATIENTS | ATAZANAVIR | Lopinavir - pharmacology | HIV-1 - drug effects | Humans | Reverse Transcriptase Inhibitors - pharmacology | HIV-1 - genetics | Mutation - genetics | Atazanavir Sulfate - therapeutic use | Protease Inhibitors - pharmacology | Drug Resistance, Viral - genetics | Darunavir - pharmacology | Point-of-Care Systems | Treatment Failure | Ritonavir - therapeutic use | Atazanavir Sulfate - pharmacology | HIV Infections - drug therapy | Lopinavir - therapeutic use | Ritonavir - pharmacology | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Genotyping Techniques - methods | Protease Inhibitors - therapeutic use | Darunavir - therapeutic use | Antiviral agents | Care and treatment | Control | Disease transmission | Genotype | Dosage and administration | Research | HIV infection | Risk factors | Antiretroviral drugs | Level (quantity) | RNA-directed DNA polymerase | Laboratories | Viruses | Drug resistance | Medical screening | Antiretroviral therapy | Load tests | Disease prevention | Inhibitors | Protease inhibitors | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Point mutation | Mutation | AIDS | HIV | Acquired immune deficiency syndrome | Human immunodeficiency virus
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 02/2019, Volume 9, Issue 1, pp. 2687 - 8
Since rapid cryptococcal antigen lateral flow assays (CrAg LFA) may expedite treatment of HIV-associated cryptococcal infections, we sought to validate... 
MENINGITIS | ANTIRETROVIRAL THERAPY | SERUM | MULTIDISCIPLINARY SCIENCES | Urine | Antigens | Human immunodeficiency virus--HIV | Antigenemia | Meningitis | Enzyme immunoassay | Blood | CD4 antigen
Journal Article
PLoS ONE, ISSN 1932-6203, 2017, Volume 12, Issue 7, p. e0181357
Journal Article